Pharmacokinetics of Snake Antivenom Following Intravenous and Intramuscular Administration in Envenomed Large Animal Model.

: The parenteral administration of antivenoms is the mainstay in snakebite envenoming therapy. The standardized protocol does not exist, but it is agreed that the intravenous () route is more effective than the others, especially the intramuscular () route, based on the monitoring of venom/antivenom pharmacokinetics in the systemic circulation. Recent evidence suggests that the lymphatic system may be crucial in abolishing venom action. A preclinical study was performed to determine the optimal administration route with emphasis on venom/antivenom interplay in both the blood and lymph of experimentally envenomed sheep. Timed level measurements were used to compare the antivenom effect on the decrement of venom quantities in both relevant body compartments. Hematological and coagulation parameters, as well as proportions of developed anti-antivenom IgGs, were evaluated. The antivenom resulted in faster and greater lymphatic absorption and complete neutralization of the venom, whereas the antivenom only slowed its absorption. The total amount of venom reaching the lymph (AUC) was two times lower after administration. In the systemic circulation, antivenom had a lower peak concentration () and a longer time to reach it (). However, the total venom exposure was three times lower than with antivenom. Irrespective of the treatment approach, both groups showed improvement in blood disorders with no significant difference in humoral response against equine F(ab') fragments. administration proved to be a viable option for the snakebite management.